View in EDS

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Saved in:
Bibliographic Details
Title: Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.
Authors: Gennari, A.1,2 (AUTHOR) alessandra.gennari@uniupo.it, Brain, E.3 (AUTHOR), De Censi, A.4 (AUTHOR), Nanni, O.5 (AUTHOR), Wuerstlein, R.6 (AUTHOR), Frassoldati, A.7 (AUTHOR), Cortes, J.8,9 (AUTHOR), Rossi, V.2 (AUTHOR), Palleschi, M.10 (AUTHOR), Alberini, J.L.11 (AUTHOR), Matteucci, F.12 (AUTHOR), Piccardo, A.13 (AUTHOR), Sacchetti, G.14 (AUTHOR), Ilhan, H.15 (AUTHOR), D'Avanzo, F.2 (AUTHOR), Ruffilli, B.1 (AUTHOR), Nardin, S.16 (AUTHOR), Monti, M.5 (AUTHOR), Puntoni, M.17 (AUTHOR), Fontana, V.18 (AUTHOR)
Source: Annals of Oncology. Jun2024, Vol. 35 Issue 6, p549-558. 10p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.02.007